These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6460101)

  • 1. 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist.
    Arvidsson LE; Hacksell U; Nilsson JL; Hjorth S; Carlsson A; Lindberg P; Sanchez D; Wikstrom H
    J Med Chem; 1981 Aug; 24(8):921-3. PubMed ID: 6460101
    [No Abstract]   [Full Text] [Related]  

  • 2. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
    Arvidsson LE; Johansson AM; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Magnusson T; Carlsson A; Andersson B; Wikström H
    J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N,N-di-n-propylserotonin: binding at serotonin binding sites and a comparison with 8-hydroxy-2-(di-n-propylamino)tetralin.
    Glennon RA; Titeler M; Lyon RA; Slusher RM
    J Med Chem; 1988 Apr; 31(4):867-70. PubMed ID: 2965244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone increases the concentration of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding [corrected] at 5-HT1A receptors in the medial preoptic nucleus of the castrated male rat.
    Mendelson SD; McEwen BS
    Eur J Pharmacol; 1990 Jun; 181(3):329-31. PubMed ID: 2143479
    [No Abstract]   [Full Text] [Related]  

  • 5. Occurrence and pharmacological significance of metabolic ortho-hydroxylation of 5- and 8-hydroxy-2-(di-n-propylamino)tetralin.
    Wikström H; Elebring T; Hallnemo G; Andersson B; Svensson K; Carlsson A; Rollema H
    J Med Chem; 1988 Jun; 31(6):1080-4. PubMed ID: 2967374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin antagonizes the antinociceptive effect of morphine.
    Berge OG; Fasmer OB; Ogren SO; Hole K
    Neurosci Lett; 1985 Feb; 54(1):71-5. PubMed ID: 3156286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural factors of importance for 5-hydroxytryptaminergic activity. Conformational preferences and electrostatic potentials of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and some related agents.
    Arvidsson LE; Karlén A; Norinder U; Kenne L; Sundell S; Hacksell U
    J Med Chem; 1988 Jan; 31(1):212-21. PubMed ID: 2961887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 125I-Bolton-Hunter-8-methoxy-2-[N-propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies.
    Gozlan H; Ponchant M; Daval G; Verge D; Menard F; Vanhove A; Beaucourt JP; Hamon M
    J Pharmacol Exp Ther; 1988 Feb; 244(2):751-9. PubMed ID: 2964524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain.
    Hall MD; el Mestikawy S; Emerit MB; Pichat L; Hamon M; Gozlan H
    J Neurochem; 1985 Jun; 44(6):1685-96. PubMed ID: 3157780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [125I-BH-8-MeO-N-PAT, a new ligand for the study of 5-HT1A receptors in the central nervous system].
    Ponchant M; Beaucourt JP; Vanhove A; Daval G; Vergé D; Hamon M; Gozlan H
    C R Acad Sci III; 1988; 306(4):147-52. PubMed ID: 2965963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Mellin C; Björk L; Karlén A; Johansson AM; Sundell S; Kenne L; Nelson DL; Andén NE; Hacksell U
    J Med Chem; 1988 Jun; 31(6):1130-40. PubMed ID: 2967376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of the novel serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin in normal and Alzheimer brain.
    Middlemiss DN; Palmer AM; Edel N; Bowen DM
    J Neurochem; 1986 Mar; 46(3):993-6. PubMed ID: 2419502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain.
    Marcinkiewicz M; Vergé D; Gozlan H; Pichat L; Hamon M
    Brain Res; 1984 Jan; 291(1):159-63. PubMed ID: 6230136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal 8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding site densities, serotonin receptor (5-HT1A) messenger ribonucleic acid abundance, and serotonin levels parallel the activity of the hypothalamopituitary-adrenal axis in rat.
    Burnet PW; Mefford IN; Smith CC; Gold PW; Sternberg EM
    J Neurochem; 1992 Sep; 59(3):1062-70. PubMed ID: 1379629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel [(diazomethyl)carbonyl]-1,2,3,4-tetrahydronaphthalene derivatives as potential photoaffinity ligands for the 5-HT1A receptor.
    Kline TB; Nelson DL; Namboodiri K
    J Med Chem; 1990 Mar; 33(3):950-5. PubMed ID: 2137880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT.
    Gozlan H; El Mestikawy S; Pichat L; Glowinski J; Hamon M
    Nature; 1983 Sep 8-14; 305(5930):140-2. PubMed ID: 6225026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin-1A receptor activation in hippocampal CA1 neurons by 8-hydroxy-2-(di-n-propylamino)tetralin, 5-methoxytryptamine and 5-hydroxytryptamine.
    Wu PH; Gurevich N; Carlen PL
    Neurosci Lett; 1988 Mar; 86(1):72-6. PubMed ID: 2966313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites.
    Naiman N; Lyon RA; Bullock AE; Rydelek LT; Titeler M; Glennon RA
    J Med Chem; 1989 Jan; 32(1):253-6. PubMed ID: 2521252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT).
    Schlegel JR; Peroutka SJ
    Biochem Pharmacol; 1986 Jun; 35(12):1943-9. PubMed ID: 3013203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site.
    Middlemiss DN; Fozard JR
    Eur J Pharmacol; 1983 May; 90(1):151-3. PubMed ID: 6223827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.